New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Maharashtra Govt Forms Six Vigilance Teams Across Revenue Divisions To Probe Complaints And Boost Transparency
Supreme Court Directs States To Deploy More Staff For SIR After Noting Harsh Conditions Faced By BLOs Nationwide
'Darker Side Of Chinese Brands:' OnePlus AI Writer Tool Crashes At The Mention Of Arunachal Pradesh
Vladimir Putin's India Visit Day 2: From Bilateral Talks With PM Modi To State Dinner; What's On Agenda For Russian President
